Borrower record · Q2 2026
Zavation Medical Products
As filed by Brightwood Capital Corp I · period end 30 June 2026No sector — one filer, nothing to corroborate2 name variants under review
Brightwood Capital Corp I is the only BDC lending to Zavation Medical Products: $13.7m across three positions at Q2 2026, marked at 97.5 cents. The filed maturities run to June 2029.
- Filed fair value
- $13.7m
- 3 funded positions
- Aggregate mark
- 97.5c
- cost filed on all 3 positions
- Filed spread
- 575bp
- over SOFR, one floating tranche
- Maturities to
- 2029
- earliest June 2028
- Periods on record
- 5
- Q2 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 3 funded positions filed by Brightwood Capital Corp I, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 2 filed name variants are under review against this borrower. Until they are resolved, anything filed under those names is counted nowhere on this page.
Capital structure
First-Lien Senior Secured, on the one position whose seniority a filer disclosed.
2 of 3 funded positions carry no filed seniority. Whether to classify is the filer's choice, so the unclassified value is not split here.
Rate structure
98.3% fixed by classified fair value. 1 position carries no filed interest type.
Maturity profile
2 of 3 funded positions dated3.0 years to maturity, weighted by fair value across the 2 dated positions.
Filed over time
2 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q2 2025, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
The filer reports no position on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector, and there cannot be one: the test needs two filers to agree and only one filed a label.
- Q3 2025, Q4 2025 and Q1 2026 are on record but not drawn: a different set of lenders reported them, so the totals are not comparable with the rest.
- No filed seniority on 2 of 3 funded positions.
- No maturity on 1 of 3 funded positions. Undated is left undated, not assumed.
Sign up for free
Tell me when this changes.
One lender reports Zavation Medical Products today. We will email you when a second one does, when Brightwood Capital Corp I's mark moves, or when the position leaves the schedule.
- A second BDC reports this borrower
- The filed mark moves by more than two cents
- A position goes on non-accrual or starts paying in kind
- The borrower drops out of the schedule entirely
Every filing behind this page
1 filer · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Brightwood Capital Corp I | 0001895316 | 10-Q | 2026-06-30 | 2026-08-11 | 0001104659-26-094146 |
Related borrowers
Same lender